|
Section 1 Immunology and Genetics. |
|
|
|
|
|
1 The Immune Response to Organ Allografts. |
|
|
|
|
|
2 Allorecognition Pathways. |
|
|
|
|
|
|
|
|
|
4 The HLA System and Histocompatibility Testing for Organ Transplantation. |
|
|
|
|
|
5 Gene Polymorphisms and Pharmacogenomics. |
|
|
|
|
|
6 Genomics and Proteomics as Research Tools. |
|
|
|
|
|
7 Tolerance: A Review of its Mechanisms in the Transplant Setting. |
|
|
|
|
|
Section 2 Immunosuppression and its Complications. |
|
|
|
|
|
8 Mechanisms of Action of Immunosuppressive Agents. |
|
|
|
|
|
9 Induction and Maintenance Immunosuppression. |
|
|
|
|
|
10 Novel Immunosuppressants. |
|
|
|
|
|
11 Therapies for the Allosensitized Patient. |
|
|
|
|
|
12 Infections Post-Transplantation. |
|
|
|
|
|
13 Post-Transplant Lymphoproliferative Disorders and Malignancy. |
|
|
|
|
|
|
|
|
|
Section 3 Kidney Transplantation. |
|
|
|
|
|
|
|
|
|
16 Recipient Characteristics. |
|
|
|
|
|
17 Evaluation of the Candidate. |
|
|
|
|
|
18 Donor Evaluation, Surgical Technique and Perioperative Management. |
|
|
|
|
|
19 Pathology of the Kidney Allograft. |
|
|
|
|
|
20 Post-Transplant Management. |
|
|
|
|
|
21 Outcomes and Risk Factors. |
|
|
|
|
|
Section 4 Liver Transplantation. |
|
|
|
|
|
|
|
|
|
23 Recipient Characteristics. |
|
|
|
|
|
24 Evaluation of the Candidate. |
|
|
|
|
|
25 Donor Evaluation, Surgical Technique and Perioperative Management. |
|
|
|
|
|
26 Pathology of the Liver Allograft. |
|
|
|
|
|
27 Post-Transplant Management. |
|
|
|
|
|
28 Outcomes and Risk Factors. |
|
|
|
|
|
Section 5 Heart Transplantation. |
|
|
|
|
|
|
|
|
|
30 Recipient Characteristics. |
|
|
|
|
|
31 Evaluation of the Candidate. |
|
|
|
|
|
32 Donor Evaluation, Surgical Technique and Perioperative Management. |
|
|
|
|
|
33 Pathology of the Cardiac Allograft. |
|
|
|
|
|
34 Post-Transplant Management. |
|
|
|
|
|
35 Outcomes and Risk Factors. |
|
|
|
|
|
Section 6 Lung and Heart-Lung Transplantation. |
|
|
|
|
|
|
|
|
|
37 Recipient Characteristics. |
|
|
|
|
|
38 Evaluation of the Candidate. |
|
|
|
|
|
39 Donor Evaluation, Surgical Technique and Perioperative Management. |
|
|
|
|
|
40 Pathology of the Lung Allograft. |
|
|
|
|
|
41 Post-Transplant Management. |
|
|
|
|
|
42 Outcomes and Risk Factors. |
|
|
|
|
|
Section 7 Intestinal Transplantation. |
|
|
|
|
|
|
|
|
|
44 Recipient Characteristics. |
|
|
|
|
|
45 Evaluation of the Candidate. |
|
|
|
|
|
46 Donor Evaluation, Surgical Technique and Perioperative Management. |
|
|
|
|
|
47 Pathology of the Intestinal Allograft. |
|
|
|
|
|
48 Post-Transplant Management. |
|
|
|
|
|
49 Outcomes and Risk Factors. |
|
|
|
|
|
Section 8 Special Issues after Pediatric Transplantation. |
|
|
|
|
|
|
|
|
|
51 Cognitive Development. |
|
|
|
|
|
52 Psychosocial Adaptation and Adherence . |
|
|
|
|
|
|
|
|
|
|
|
|
|
55 Transition to Adult Care. |
|
|
|
|
|
|